schliessen

Filtern

 

Bibliotheken

Cover Image

Thymidine phosphorylase: A potential new target for treating cardiovascular disease

We recently found that thymidine phosphorylase (TYMP), also known as platelet-derived endothelial cell growth factor, plays an important role in platelet activation in vitro and thrombosis in vivo by participating in multiple signaling pathways. Platelets are a major source of TYMP. Since platelet-m... Full description

Journal Title: Trends in cardiovascular medicine 2018-04, Vol.28 (3), p.157-171
Main Author: Li, Wei
Other Authors: Yue, Hong
Format: Electronic Article Electronic Article
Language: English
Subjects:
Angiogenesis
Animals
Article
Cancer
Cardiovascular Agents - adverse effects
Cardiovascular Agents - therapeutic use
Cardiovascular diseases
Cardiovascular Diseases - drug therapy
Cardiovascular Diseases - enzymology
Cardiovascular Diseases - genetics
Cell growth
Cerebral infarction
Disease
Drug Discovery - methods
Embolism
Endothelial cells
Enzyme Inhibitors - adverse effects
Enzyme Inhibitors - therapeutic use
Enzymes
Gene Expression Regulation, Enzymologic
Growth factors
Humans
Kinases
Mammals
Molecular modelling
Molecular Targeted Therapy - adverse effects
Molecular Targeted Therapy - methods
Mutation
Myocardial infarction
Phosphate esters
Phosphorylase
Platelet-derived endothelial cell growth factor
Platelets
Protein Conformation
Proteins
Stroke
Structure-Activity Relationship
Thrombosis
Thymidine
Thymidine phosphorylase
Thymidine Phosphorylase - antagonists & inhibitors
Thymidine Phosphorylase - chemistry
Thymidine Phosphorylase - genetics
Thymidine Phosphorylase - metabolism
Tumors
Quelle: Alma/SFX Local Collection
Publisher: United States: Elsevier Inc
ID: ISSN: 1050-1738
Link: https://www.ncbi.nlm.nih.gov/pubmed/29108898
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5856583
title: Thymidine phosphorylase: A potential new target for treating cardiovascular disease
format: Article
creator:
  • Li, Wei
  • Yue, Hong
subjects:
  • Angiogenesis
  • Animals
  • Article
  • Cancer
  • Cardiovascular Agents - adverse effects
  • Cardiovascular Agents - therapeutic use
  • Cardiovascular diseases
  • Cardiovascular Diseases - drug therapy
  • Cardiovascular Diseases - enzymology
  • Cardiovascular Diseases - genetics
  • Cell growth
  • Cerebral infarction
  • Disease
  • Drug Discovery - methods
  • Embolism
  • Endothelial cells
  • Enzyme Inhibitors - adverse effects
  • Enzyme Inhibitors - therapeutic use
  • Enzymes
  • Gene Expression Regulation, Enzymologic
  • Growth factors
  • Humans
  • Kinases
  • Mammals
  • Molecular modelling
  • Molecular Targeted Therapy - adverse effects
  • Molecular Targeted Therapy - methods
  • Mutation
  • Myocardial infarction
  • Phosphate esters
  • Phosphorylase
  • Platelet-derived endothelial cell growth factor
  • Platelets
  • Protein Conformation
  • Proteins
  • Stroke
  • Structure-Activity Relationship
  • Thrombosis
  • Thymidine
  • Thymidine phosphorylase
  • Thymidine Phosphorylase - antagonists & inhibitors
  • Thymidine Phosphorylase - chemistry
  • Thymidine Phosphorylase - genetics
  • Thymidine Phosphorylase - metabolism
  • Tumors
ispartof: Trends in cardiovascular medicine, 2018-04, Vol.28 (3), p.157-171
description: We recently found that thymidine phosphorylase (TYMP), also known as platelet-derived endothelial cell growth factor, plays an important role in platelet activation in vitro and thrombosis in vivo by participating in multiple signaling pathways. Platelets are a major source of TYMP. Since platelet-mediated clot formation is a key event in several fatal diseases, such as myocardial infarction, stroke and pulmonary embolism, understanding TYMP in depth may lead to uncovering novel mechanisms in the development of cardiovascular diseases. Targeting TYMP may become a novel therapeutic for cardiovascular disorders. In this review article, we summarize the discovery of TYMP and the potential molecular mechanisms of TYMP involved in the development of various diseases, especially cardiovascular diseases. We also offer insights regarding future studies exploring the role of TYMP in the development of cardiovascular disease as well as in therapy.
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 1050-1738
fulltext: fulltext
issn:
  • 1050-1738
  • 1873-2615
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.5681558
LOCALfalse
PrimoNMBib
record
control
sourceidproquest_pubme
recordidTN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5856583
sourceformatXML
sourcesystemPC
sourcerecordid1961635542
originalsourceidFETCH-LOGICAL-1501t-11bf84dda115c39682ca6e6b9a9c62f7408bda26eea148a77ac7404f7ba1cab3
addsrcrecordideNp9UU2P0zAQjRCIXRZ-ABcUiQuXFE8SfwQkpNUKWKSVONC7NbEnraskDrZb1H-Pqy4rlgMHyzPj956e5xXFa2ArYCDe71bJTKuagcz9irHmSXEJSjZVLYA_zTXjrALZqIviRYw7xphoBTwvLuoOmFKduix-rLfHyVk3U7lsfcwnHEeM9KG8LhefaE4Ox3KmX2XCsKFUDj6UKRAmN29Kg8E6f8Bo9iOG0rpImfuyeDbgGOnV_X1VrL98Xt_cVnffv367ub6rgDNIFUA_qNZaBOCm6YSqDQoSfYedEfUgW6Z6i7UgQmgVSokmz9pB9ggG--aq-HSWXfb9RNZkrwFHvQQ3YThqj04_fpndVm_8QXPFBVdNFrg9C_iFZnSBHnHtTEl7q2shdV-LnjrWqs5wENgbWXNLjLDLhVAsS7279xL8zz3FpCcXDY0jzuT3UUMnQDSct3WGvv0HuvP7MOdF6Zxk2wjZQJdRcEaZ4GMMNDx4A6ZP4eudzuGfKPI0yuFnzpu_F_LA-JN2Bnw8AyincnAUdDSOZkM2f94kbb37j_xv4FDAMQ
sourcetypeOpen Access Repository
isCDItrue
recordtypearticle
pqid2014367319
display
typearticle
titleThymidine phosphorylase: A potential new target for treating cardiovascular disease
sourceAlma/SFX Local Collection
creatorLi, Wei ; Yue, Hong
creatorcontribLi, Wei ; Yue, Hong
descriptionWe recently found that thymidine phosphorylase (TYMP), also known as platelet-derived endothelial cell growth factor, plays an important role in platelet activation in vitro and thrombosis in vivo by participating in multiple signaling pathways. Platelets are a major source of TYMP. Since platelet-mediated clot formation is a key event in several fatal diseases, such as myocardial infarction, stroke and pulmonary embolism, understanding TYMP in depth may lead to uncovering novel mechanisms in the development of cardiovascular diseases. Targeting TYMP may become a novel therapeutic for cardiovascular disorders. In this review article, we summarize the discovery of TYMP and the potential molecular mechanisms of TYMP involved in the development of various diseases, especially cardiovascular diseases. We also offer insights regarding future studies exploring the role of TYMP in the development of cardiovascular disease as well as in therapy.
identifier
0ISSN: 1050-1738
1EISSN: 1873-2615
2DOI: 10.1016/j.tcm.2017.10.003
3PMID: 29108898
languageeng
publisherUnited States: Elsevier Inc
subjectAngiogenesis ; Animals ; Article ; Cancer ; Cardiovascular Agents - adverse effects ; Cardiovascular Agents - therapeutic use ; Cardiovascular diseases ; Cardiovascular Diseases - drug therapy ; Cardiovascular Diseases - enzymology ; Cardiovascular Diseases - genetics ; Cell growth ; Cerebral infarction ; Disease ; Drug Discovery - methods ; Embolism ; Endothelial cells ; Enzyme Inhibitors - adverse effects ; Enzyme Inhibitors - therapeutic use ; Enzymes ; Gene Expression Regulation, Enzymologic ; Growth factors ; Humans ; Kinases ; Mammals ; Molecular modelling ; Molecular Targeted Therapy - adverse effects ; Molecular Targeted Therapy - methods ; Mutation ; Myocardial infarction ; Phosphate esters ; Phosphorylase ; Platelet-derived endothelial cell growth factor ; Platelets ; Protein Conformation ; Proteins ; Stroke ; Structure-Activity Relationship ; Thrombosis ; Thymidine ; Thymidine phosphorylase ; Thymidine Phosphorylase - antagonists & inhibitors ; Thymidine Phosphorylase - chemistry ; Thymidine Phosphorylase - genetics ; Thymidine Phosphorylase - metabolism ; Tumors
ispartofTrends in cardiovascular medicine, 2018-04, Vol.28 (3), p.157-171
rights
02018 Elsevier Inc.
1Copyright © 2018 Elsevier Inc. All rights reserved.
2Copyright Elsevier Limited 2018
lds50peer_reviewed
oafree_for_read
orcidid0000-0002-7973-6242
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29108898$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Li, Wei
1Yue, Hong
title
0Thymidine phosphorylase: A potential new target for treating cardiovascular disease
1Trends in cardiovascular medicine
addtitleTrends Cardiovasc Med
descriptionWe recently found that thymidine phosphorylase (TYMP), also known as platelet-derived endothelial cell growth factor, plays an important role in platelet activation in vitro and thrombosis in vivo by participating in multiple signaling pathways. Platelets are a major source of TYMP. Since platelet-mediated clot formation is a key event in several fatal diseases, such as myocardial infarction, stroke and pulmonary embolism, understanding TYMP in depth may lead to uncovering novel mechanisms in the development of cardiovascular diseases. Targeting TYMP may become a novel therapeutic for cardiovascular disorders. In this review article, we summarize the discovery of TYMP and the potential molecular mechanisms of TYMP involved in the development of various diseases, especially cardiovascular diseases. We also offer insights regarding future studies exploring the role of TYMP in the development of cardiovascular disease as well as in therapy.
subject
0Angiogenesis
1Animals
2Article
3Cancer
4Cardiovascular Agents - adverse effects
5Cardiovascular Agents - therapeutic use
6Cardiovascular diseases
7Cardiovascular Diseases - drug therapy
8Cardiovascular Diseases - enzymology
9Cardiovascular Diseases - genetics
10Cell growth
11Cerebral infarction
12Disease
13Drug Discovery - methods
14Embolism
15Endothelial cells
16Enzyme Inhibitors - adverse effects
17Enzyme Inhibitors - therapeutic use
18Enzymes
19Gene Expression Regulation, Enzymologic
20Growth factors
21Humans
22Kinases
23Mammals
24Molecular modelling
25Molecular Targeted Therapy - adverse effects
26Molecular Targeted Therapy - methods
27Mutation
28Myocardial infarction
29Phosphate esters
30Phosphorylase
31Platelet-derived endothelial cell growth factor
32Platelets
33Protein Conformation
34Proteins
35Stroke
36Structure-Activity Relationship
37Thrombosis
38Thymidine
39Thymidine phosphorylase
40Thymidine Phosphorylase - antagonists & inhibitors
41Thymidine Phosphorylase - chemistry
42Thymidine Phosphorylase - genetics
43Thymidine Phosphorylase - metabolism
44Tumors
issn
01050-1738
11873-2615
fulltexttrue
rsrctypearticle
creationdate2018
recordtypearticle
recordideNp9UU2P0zAQjRCIXRZ-ABcUiQuXFE8SfwQkpNUKWKSVONC7NbEnraskDrZb1H-Pqy4rlgMHyzPj956e5xXFa2ArYCDe71bJTKuagcz9irHmSXEJSjZVLYA_zTXjrALZqIviRYw7xphoBTwvLuoOmFKduix-rLfHyVk3U7lsfcwnHEeM9KG8LhefaE4Ox3KmX2XCsKFUDj6UKRAmN29Kg8E6f8Bo9iOG0rpImfuyeDbgGOnV_X1VrL98Xt_cVnffv367ub6rgDNIFUA_qNZaBOCm6YSqDQoSfYedEfUgW6Z6i7UgQmgVSokmz9pB9ggG--aq-HSWXfb9RNZkrwFHvQQ3YThqj04_fpndVm_8QXPFBVdNFrg9C_iFZnSBHnHtTEl7q2shdV-LnjrWqs5wENgbWXNLjLDLhVAsS7279xL8zz3FpCcXDY0jzuT3UUMnQDSct3WGvv0HuvP7MOdF6Zxk2wjZQJdRcEaZ4GMMNDx4A6ZP4eudzuGfKPI0yuFnzpu_F_LA-JN2Bnw8AyincnAUdDSOZkM2f94kbb37j_xv4FDAMQ
startdate201804
enddate201804
creator
0Li, Wei
1Yue, Hong
general
0Elsevier Inc
1Elsevier Limited
scope
0CGR
1CUY
2CVF
3ECM
4EIF
5NPM
6AAYXX
7CITATION
83V.
97RV
107TK
117X7
127XB
1388E
148FI
158FJ
168FK
178G5
18ABUWG
19AZQEC
20BENPR
21DWQXO
22FYUFA
23GHDGH
24GNUQQ
25GUQSH
26K9.
27KB0
28M0S
29M1P
30M2O
31MBDVC
32NAPCQ
33PADUT
34PQEST
35PQQKQ
36PQUKI
37PRINS
38Q9U
397X8
40BOBZL
41CLFQK
425PM
orcididhttps://orcid.org/0000-0002-7973-6242
sort
creationdate201804
titleThymidine phosphorylase: A potential new target for treating cardiovascular disease
authorLi, Wei ; Yue, Hong
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-1501t-11bf84dda115c39682ca6e6b9a9c62f7408bda26eea148a77ac7404f7ba1cab3
rsrctypearticles
prefilterarticles
languageeng
creationdate2018
topic
0Angiogenesis
1Animals
2Article
3Cancer
4Cardiovascular Agents - adverse effects
5Cardiovascular Agents - therapeutic use
6Cardiovascular diseases
7Cardiovascular Diseases - drug therapy
8Cardiovascular Diseases - enzymology
9Cardiovascular Diseases - genetics
10Cell growth
11Cerebral infarction
12Disease
13Drug Discovery - methods
14Embolism
15Endothelial cells
16Enzyme Inhibitors - adverse effects
17Enzyme Inhibitors - therapeutic use
18Enzymes
19Gene Expression Regulation, Enzymologic
20Growth factors
21Humans
22Kinases
23Mammals
24Molecular modelling
25Molecular Targeted Therapy - adverse effects
26Molecular Targeted Therapy - methods
27Mutation
28Myocardial infarction
29Phosphate esters
30Phosphorylase
31Platelet-derived endothelial cell growth factor
32Platelets
33Protein Conformation
34Proteins
35Stroke
36Structure-Activity Relationship
37Thrombosis
38Thymidine
39Thymidine phosphorylase
40Thymidine Phosphorylase - antagonists & inhibitors
41Thymidine Phosphorylase - chemistry
42Thymidine Phosphorylase - genetics
43Thymidine Phosphorylase - metabolism
44Tumors
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Li, Wei
1Yue, Hong
collection
0Medline
1MEDLINE
2MEDLINE (Ovid)
3MEDLINE
4MEDLINE
5PubMed
6CrossRef
7ProQuest Central (Corporate)
8Nursing & Allied Health Database
9Neurosciences Abstracts
10Health & Medical Collection
11ProQuest Central (purchase pre-March 2016)
12Medical Database (Alumni Edition)
13Hospital Premium Collection
14Hospital Premium Collection (Alumni Edition)
15ProQuest Central (Alumni) (purchase pre-March 2016)
16Research Library (Alumni Edition)
17ProQuest Central (Alumni Edition)
18ProQuest Central Essentials
19ProQuest Central
20ProQuest Central Korea
21Health Research Premium Collection
22Health Research Premium Collection (Alumni)
23ProQuest Central Student
24Research Library Prep
25ProQuest Health & Medical Complete (Alumni)
26Nursing & Allied Health Database (Alumni Edition)
27Health & Medical Collection (Alumni Edition)
28Medical Database
29Research Library
30Research Library (Corporate)
31Nursing & Allied Health Premium
32Research Library China
33ProQuest One Academic Eastern Edition
34ProQuest One Academic
35ProQuest One Academic UKI Edition
36ProQuest Central China
37ProQuest Central Basic
38MEDLINE - Academic
39OpenAIRE (Open Access)
40OpenAIRE
41PubMed Central (Full Participant titles)
jtitleTrends in cardiovascular medicine
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Li, Wei
1Yue, Hong
formatjournal
genrearticle
ristypeJOUR
atitleThymidine phosphorylase: A potential new target for treating cardiovascular disease
jtitleTrends in cardiovascular medicine
addtitleTrends Cardiovasc Med
date2018-04
risdate2018
volume28
issue3
spage157
epage171
pages157-171
issn1050-1738
eissn1873-2615
abstractWe recently found that thymidine phosphorylase (TYMP), also known as platelet-derived endothelial cell growth factor, plays an important role in platelet activation in vitro and thrombosis in vivo by participating in multiple signaling pathways. Platelets are a major source of TYMP. Since platelet-mediated clot formation is a key event in several fatal diseases, such as myocardial infarction, stroke and pulmonary embolism, understanding TYMP in depth may lead to uncovering novel mechanisms in the development of cardiovascular diseases. Targeting TYMP may become a novel therapeutic for cardiovascular disorders. In this review article, we summarize the discovery of TYMP and the potential molecular mechanisms of TYMP involved in the development of various diseases, especially cardiovascular diseases. We also offer insights regarding future studies exploring the role of TYMP in the development of cardiovascular disease as well as in therapy.
copUnited States
pubElsevier Inc
pmid29108898
doi10.1016/j.tcm.2017.10.003
orcididhttps://orcid.org/0000-0002-7973-6242
oafree_for_read